Seasonal Allergic Conjunctivitis Clinical Trial
Official title:
Evaluation of the Combination Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to Its Components and Vehicle in an Allergen BioCube® in Subjects With Seasonal Allergic Conjunctivitis
To evaluate the efficacy of Combo compared to its individual components and compared to vehicle in a population of subjects with seasonal allergic conjunctivitis.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01541904 -
Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis
|
Phase 2 | |
Completed |
NCT06212973 -
A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients
|
Phase 3 | |
Completed |
NCT01435460 -
Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)
|
Phase 3 | |
Completed |
NCT01344083 -
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
|
Phase 2 | |
Completed |
NCT01342601 -
Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents
|
N/A | |
Completed |
NCT00133627 -
Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis
|
Phase 4 |